Abstract
1. Sera of human subjects immunized with pneumococci or their type-specific polysaccharides showed type-specific antibody by mouse protection tests as well as on determinations of the specifically precipitable nitrogen. 2. The ratio, mouse-protective units to antibody nitrogen, was less in human sera of low potency than in more potent human or animal sera.
Full Text
The Full Text of this article is available as a PDF (426.3 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Felton L. D. Immunization against Pneumonia. Am J Public Health Nations Health. 1940 Apr;30(4):361–368. doi: 10.2105/ajph.30.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finland M., Sutliff W. D. SPECIFIC ANTIBODY RESPONSE OF HUMAN SUBJECTS TO INTRACUTANEOUS INJECTION OF PNEUMOCOCCUS PRODUCTS. J Exp Med. 1932 May 31;55(6):853–865. doi: 10.1084/jem.55.6.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Francis T., Tillett W. S. CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE. J Exp Med. 1930 Sep 30;52(4):573–585. doi: 10.1084/jem.52.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goodner K., Horsfall F. L. PROPERTIES OF THE TYPE SPECIFIC PROTEINS OF ANTIPNEUMOCOCCUS SERA : I. THE MOUSE PROTECTIVE VALUE OF TYPE I SERA WITH REFERENCE TO THE PRECIPITIN CONTENT. J Exp Med. 1937 Sep 30;66(4):413–424. doi: 10.1084/jem.66.4.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heidelberger M., Macleod C. M., Kaiser S. J., Robinson B. ANTIBODY FORMATION IN VOLUNTEERS FOLLOWING INJECTION OF PNEUMOCOCCI OR THEIR TYPE-SPECIFIC POLYSACCHARIDES. J Exp Med. 1946 Mar 31;83(4):303–320. [PMC free article] [PubMed] [Google Scholar]